RA in practice Flashcards
what is the pharmacists role in RA?
signposting to further support or iitial diagnosis
high risk drugs- ensuring drugs are used safely
support for systemic conditions
general lifestyle advice
support on taking medications
management of analgesia
be aware of assoicated risk factors and support
specalist pharmacist
what kind of disease is RA?
RA is a systemic disease
what are some associated conditions with RA?
• Sjörgrens syndrome - lubricating eye drops/ointments - Artificial saliva replacement • Vasculitis - steroids, cyclophosphamide.. • Increased cardiovascular risk - assessment e.g. QRISK and appropriate medication initiation • Increased osteoporosis risk - assessment e.g. FRAX (+/- DXA) and appropriate medication initiation
when may physical decterity come into play in RA? what support can be offered?
compromised due
to RA affecting hands, additional support for
taking medicines may be needed
• Child resistant containers may be difficult
– Patients can opt not to have these
• Supportive cutters, easy to open containers
(e.g. Salazopyrin ®)
• MDT- occupational therapists support patients
to maintain independent living
are DMARDs and biologics analgesics?
no
what kind of condition is RA? what can be used for symptomatic relief ?
As RA is an inflammatory condition, an anti-
inflammatory (NSAID or COX-2 inhibitor) may
be required for symptomatic relief
what are the most common DMARDs?
- Methotrexate
- Sulfasalazine
- Leflunomide
- Hydroxychloroquine
- Biologics
what is the initial recommended pharmacological treatment for RA?
Monotherapy now recommended asap
– Oral methotrexate, leflunomide, sulfasalazine
(hydroxychloroquine alternative)
– Consider bridging treatment with oral, IM or IA
glucocorticoids when initiating DMARD [st
if target is not reached after monotherapy what should be done?
If target not reached add second DMARD (methotrexate, sulfasalazine, leflunomide, hydroxychloroquine) or sequential monotherapy • Inadequate response to conventional DMARDS – Biologics (or JAK inhibitors), usually in combination with methotrexate
how long do DMARDs take to work?
weeks/months
what is the usual first line DMARDs unless C/I
Methotrexate is considered anchor drug- usual first line
unless c/I
because DMARDs have a signifigant side effect profile what monitoring should be done?
Regular blood tests
– Patient counselling
– Recognition and awareness of signs/symptoms of serious
adverse effects
what advice is given to RA patients about vaccinations?
– Flu, pneumococcal recommended
– Avoid live vaccines (give 2-4 weeks before starting
immunosuppressive where possible)
– Avoid contact with chicken pox/shingles/measles. Ensure
household contacts immune to measles: offer MMR
– Significant contact with chicken pox: VZ immunoglobulin
can be given within 7 days of contact, measles: urgent
measles IgG testing
who are the people who are on immunocompromised therapy that are more likely to suffer clinical infections?
leflunomide, methotrexate,
biologics more likely to suffer clinically significant infections
what happens if someone with RA needs antibiotics for an infection?
mmunosuppressive agents for RA
usually stopped until infection cleared.
when should methotrexate be taken?
once weekly- on the same day
who should be prescribed methotrexate?
nly be prescribed by
HCP who are fully aware of benefits/risks and
have all necessary prescribing competence
why should folic acid be given with methotrexate? what day should it be given on?
Should be given to reduce adverse effects (but
not on methotrexate day)
• E.g.
– Once a week on a different day to methotrexate
– Three times a week
– Every day apart from methotrexate day
what clinical checks of methotrexate should be done?
Check patients previous dose (PMR, patient)
– If not the same, is dose increase/decrease reasonable?
– Is patient expecting dose change?
– Check purple book- bloods/dose
– Discuss any concerns regarding bloods with prescriber &
document this
what drugs interact with methotrexate?
e.g. antifolate effects (phenytoin, trimethoprim), various herbal
preparations, increased monitoring vigilance and caution with
leflunomide.
• Alcohol + Methotrexate can both increase risk of liver damage-
uncertainty about safe levels